Billion Dollar Battle

Sir Paul Girolami, head of Glaxo, and Roy Vagelos, head of Merck, are vying for control of the world's most profitable industry - medical drugs. Their two companies dominate the business - Glaxo of Britain makes profits of a billion pounds a year, and Merck of America has been voted for three successive years the most admired company in the "Fortune" poll of international businessmen. Based on interviews with these two internationally-admired chief executives, this is an account of the battle between them, and of their contrasting styles.